CraftAWAmineddineHAScottJESWaggetJ.The Northern Region Children's Malignant Disease Registry, 1968–1982: Incidence and survival. Br J Cancer1987;56:853–8.
2.
StillerCA. Trends in neuroblastoma in Great Britain: Incidence and mortality, 1971–1990. Eur J Cancer1993;29a:1008–12.
3.
StillerCABunchKJ. Trends in survival for childhood cancer in Britain diagnosed 1971–85. Br J Cancer1990;62:806–15.
4.
CraftAWParkerL.Poor prognosis neuroblastoma: Is screening the answer?Br J Cancer1992;66:s96–101.
5.
TuchmanMRamnaraineMRWoodsWGKrivitW.Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma. Pediatrics1987;79:203.
6.
SawadaTNakataTTakasugiNMass screening for neuroblastoma in infants in Japan. Lancet1984;ii:271–3.
7.
MatsumuraMTsunodaANishiTSpontaneous regression of neuroblastoma detected by mass screening. Lancet1991;338:447–8.
8.
BesshoFHashizumeKNakajoTKamoshiyaS.Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children. J Pediatr1991;119:237–41.
